About Jiangsu Nhwa Pharmaceutical Company

The company was founded in 1978 and listed on the Shenzhen Stock Exchange in 2008. It is a pharmaceutical enterprise integrating science, industry and trade. The company's main business is pharmaceutical research and development, production and sales. Pharmaceutical sales include sales of raw materials and preparations produced by the company, as well as pharmaceutical wholesale and retail business. The company's main products are the manufacture and manufacture of central nervous system products (including anesthetic, psychotropic and neurological pharmaceutical raw materials and their preparations). Corporate honors: Jiangsu Green Factory, National Advanced Employment and Social Security Private Enterprise, Tax Credit Class A Enterprise, “AAA” Credit Rating Certificate issued by Jiangsu Zhongchengxin Credit Management Co., Ltd., “Five-star Brand Certification” and “Five-star After-sales Service Certification” issued by Beijing Huayuan Runze International Certification Co., Ltd., ranked 85th in the 2023 China Pharmaceutical Industry Top 100 Enterprises, selected for the 2021 Jiangsu Top Ten Corporate Social Responsibility Construction Industry List, “Environmental Management System Certification” issued by the China Quality Certification Center, China Quality Certification Center in 2023 Pharmaceutical research and development strength ranked 26th, ranked 43rd in the 2023 Jiangsu Private Enterprise Innovation Top 100, Xuzhou's first batch of environmental protection demonstration enterprises in 2023, and excellent quality management enterprises in the pharmaceutical industry in Jiangsu Province in 2023.